Compare TELA & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TELA | NBY |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.5M | 31.6M |
| IPO Year | 2019 | 2007 |
| Metric | TELA | NBY |
|---|---|---|
| Price | $0.57 | $1.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | 152.0K | ★ 628.0K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.59 | 35.42 |
| EPS | N/A | ★ 0.76 |
| Revenue | ★ $80,275,000.00 | $370,000.00 |
| Revenue This Year | $17.75 | N/A |
| Revenue Next Year | $16.45 | N/A |
| P/E Ratio | ★ N/A | $2.57 |
| Revenue Growth | ★ 15.84 | N/A |
| 52 Week Low | $0.50 | $0.43 |
| 52 Week High | $2.19 | $19.95 |
| Indicator | TELA | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 38.49 | 57.82 |
| Support Level | N/A | $1.01 |
| Resistance Level | $1.24 | $2.52 |
| Average True Range (ATR) | 0.12 | 0.26 |
| MACD | -0.02 | 0.11 |
| Stochastic Oscillator | 24.18 | 96.45 |
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.